A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies
Clinical trial NCT03926143 · TERMINATED
Trial details
- NCT number
- NCT03926143
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2022-05-18
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.